This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Armin Schneider - Innovator in Neurological Treatments
Introduction
Armin Schneider is a notable inventor based in Germany, recognized for his contributions to the field of neurology. He has developed innovative methods aimed at treating neurological conditions through the use of hematopoietic growth factors. His work is significant in advancing therapeutic options for patients suffering from various neurological disorders.
Latest Patents
Armin Schneider holds a patent titled "Methods Of Treating Neurological Conditions With Hematopoietic Growth Factors." This invention relates to a method of treating neurological conditions in mammals by administering hematopoietic growth factors such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony stimulating factor (GMCSF). The patent also outlines methods for screening compounds that bind to GCSF or GMCSF receptors found on neuronal cells, which can provide neuroprotective, neuroproliferative, and/or STAT gene activation activities. Notably, he currently has 0 patents.
Career Highlights
Armin Schneider is associated with Neurovision Pharma GmbH, where he applies his expertise in developing treatments for neurological conditions. His work at the company focuses on innovative approaches to enhance patient care and improve outcomes for those affected by neurological disorders.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Armin Schneider's innovative methods in treating neurological conditions highlight his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies in neurology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile